The public's enthusiasm for stem cell research has focused on the potential of the cells to treat disease and traumatic injury. Theoretically, if scientists could deduce how to prompt embryonic or adult stem cells ...

The campus community is invited to learn about public safety at upcoming fairs at three UCSF locations.

UCSF Transportation Services is not immune to the pain at the pump, as gas prices hit new highs this summer.

Immunization clinics will begin today, Monday, Aug. 29 and continue through Thursday, Sept.1, at several San Francisco public schools.

Respondents in the recent survey about the Parnassus campus offered a lot of recommendations on how to improve the 13-acre site.

UCSF scientists Elissa Epel, PhD, and Elizabeth Blackburn, PhD, are featured in a piece scheduled to air tonight, Friday, Aug. 26 at 8 p.m. on CBS 60 Minutes II.

A new drug has been proven in clinical trials to prevent acute kidney transplant rejection with few toxic side effects, researchers say.

Following site visits in April, the Commission on Dental Accreditation gave the UCSF School of Dentistry a glowing final report.

In an international clinical trial, a new drug that selectively blocks immune responses has proved as effective in preventing acute kidney transplant rejection as cyclosporine, the standard anti-rejection treatment.

Investigators describe how intramural awards enable them to collect new data, test emergent hypotheses and move in new directions.